Related Experiment Video

Updated: Jul 4, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

Amiodarone protects diabetics and non-diabetics undergoing coronary artery bypass grafting equally

Lars R Zebis1, Thomas D Christensen, Henrik F Thomsen

  • 1Department of Cardiothoracic and Vascular Surgery & Institute of Clinical Medicine, Aarhus University Hospital, Skejby, Aarhus N, Denmark. LRZ@post.tele.dk

Scandinavian Cardiovascular Journal : SCJ
|June 24, 2008
PubMed

Insights

Amiodarone prophylaxis is equally effective for diabetics and non-diabetics in preventing atrial fibrillation. However, diabetic patients experienced a longer hospital stay, indicating a potential complication beyond arrhythmia risk.

Area of Science:

  • Cardiology
  • Endocrinology
  • Clinical Trials

Background:

  • Diabetes mellitus is a growing global health concern.
  • Atrial fibrillation (AF) is a common complication following cardiac surgery.
  • Diabetic patients often have poorer outcomes and longer hospital stays after cardiac procedures.

Purpose of the Study:

  • To assess amiodarone prophylaxis efficacy in diabetic versus non-diabetic patients.
  • To determine if diabetic status influences atrial fibrillation risk.
  • To evaluate the impact of diabetes on in-hospital stay duration post-cardiac procedures.

Main Methods:

  • Subgroup analysis from a randomized, controlled, double-blinded trial.
  • Comparison of atrial fibrillation incidence at 30 days.
  • Analysis of in-hospital stay length between diabetic and non-diabetic cohorts.

Main Results:

  • Atrial fibrillation incidence was similar: 22% in diabetics vs. 17% in non-diabetics (p=0.41).
  • Amiodarone prophylaxis demonstrated comparable efficacy in both groups.
  • Diabetic patients had a significantly prolonged in-hospital stay (25% longer).

Conclusions:

  • Amiodarone prophylaxis is equally effective for diabetic and non-diabetic patients regarding atrial fibrillation prevention.
  • Diabetic status does not increase atrial fibrillation risk in this context.
  • Diabetes is associated with increased length of in-hospital stay, independent of AF development.
Abstract

More Related Videos

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...